Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 37,256 shares at $54.50 ($2.0M) on 2023-08-29, disclosed to the SEC on 2023-08-30.
Scheduled sale ($2.0M) by EVP&Pres, Periph Intervent under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.14 | 13,971 | $742K | 37.3% |
| 2 | $53.14 | 13,971 | $742K | 37.3% |
| 3 | $54.50 | 4,657 | $254K | 12.7% |
| 4 | $54.50 | 4,657 | $254K | 12.7% |
| Total | $53.48 avg | 37,256 | $2.0M | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |